Finanznachrichten31 分钟
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of ...
About LimmaTech Biologics AG LimmaTech Biologics is at the forefront of combating the global antimicrobial resistance epidemic based on its unparalleled ... unexpected clinical trial results, ...